paclitaxel has been researched along with Anaplastic Astrocytoma in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (62.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deckert, M; Hans, V; Kristof, RA; Neuloh, G; Schlegel, U; Schramm, J; Simon, M; Urbach, H | 1 |
| Baayen, HC; Barkhof, F; Boogerd, W; Castelijns, JA; Elkhuizen, PH; Heimans, JJ; Postma, TJ; Uitdehaag, BM; Vos, MJ | 1 |
| Cromwell, LD; Fadul, CE; Kingman, LS; McDonnell, CE; Meyer, LP; Pipas, JM; Rhodes, CH; Rigas, JR | 1 |
| Chung, DY; Ja Jhon, G; Lee, SJ; Lee, YJ; Lee, YS | 1 |
| Akerley, W; Choy, H; Egorin, MJ; Glantz, MJ; Kearns, CM | 1 |
| Geard, CR; Gubits, RM; Schiff, PB | 1 |
| Cook, JA; Fisher, J; Liebmann, JE; Lipschultz, C; Mitchell, JB; Teague, D | 1 |
| Choy, H; Cole, BF; Egorin, MJ; Glantz, MJ; Kearns, CM; Mills, P; Rhodes, CH; Saris, S; Stopa, E; Zuhowski, EG | 1 |
| Akerley, W; Choy, H; Cole, BF; Egorin, MJ; Glantz, MJ; Kearns, CM; Rhodes, CH | 1 |
| Akerley, W; Choy, H; Cole, B; Cortez, S; Glantz, L; Glantz, M; Mills, P; Wehbe, T | 1 |
| Chen, J; Donovan, S; Hong, FD; Nisen, PD; Schneider, N | 1 |
| Beenen, LF; Heimans, JJ; Hoekstra, OS; Klein, M; Luykx, SA; Postma, TJ; Taphoorn, MJ; van Groeningen, CJ; Vermorken, JB; Zonnenberg, BA | 1 |
| Cairncross, JG; Fortin, D; Macdonald, DR; Stitt, L | 1 |
| Berger, MS; Bobola, MS; Silber, JR; Tseng, SH | 1 |
| Geard, CR; Hall, EJ; Schiff, PB; Tishler, RB | 2 |
5 trial(s) available for paclitaxel and Anaplastic Astrocytoma
| Article | Year |
|---|---|
A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Filgrastim; Glioblastoma; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Recombinant Proteins; Thrombocytopenia; Topotecan; Treatment Outcome | 2005 |
Weekly, outpatient paclitaxel and concurrent cranial irradiation in adults with brain tumors: preliminary results and promising directions.
Topics: Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Female; Glioblastoma; Humans; Karnofsky Performance Status; Male; Middle Aged; Nervous System Diseases; Paclitaxel; Premedication; Radiation-Sensitizing Agents; Regression Analysis; Survival Rate | 1995 |
Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Glioblastoma; Humans; Middle Aged; Paclitaxel | 1996 |
Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and response.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Agents, Phytogenic; Astrocytoma; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tumor Suppressor Protein p53 | 1996 |
A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma.
Topics: Adult; Affect; Aged; Antineoplastic Agents, Phytogenic; Astrocytoma; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Prospective Studies; Quality of Life; Survival Analysis; Treatment Outcome | 2000 |
11 other study(ies) available for paclitaxel and Anaplastic Astrocytoma
| Article | Year |
|---|---|
Combined surgery, radiation, and PCV chemotherapy for astrocytomas compared to oligodendrogliomas and oligoastrocytomas WHO grade III.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cisplatin; Cohort Studies; Combined Modality Therapy; Disease Progression; Female; Follow-Up Studies; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Staging; Oligodendroglioma; Paclitaxel; Prospective Studies; Radiotherapy; Survival Rate; Taxoids; Treatment Outcome; Vinblastine; World Health Organization | 2002 |
Interobserver variability in the radiological assessment of response to chemotherapy in glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Ependymoma; Female; Glioblastoma; Glioma; Humans; Image Enhancement; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Paclitaxel; Procarbazine; Sensitivity and Specificity; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2003 |
Enhanced radiosensitization of p53 mutant cells by oleamide.
Topics: Animals; Apoptosis; Astrocytoma; bcl-2-Associated X Protein; Cell Line, Tumor; DNA Fragmentation; Drug Screening Assays, Antitumor; Genes, p53; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Mitochondrial Membranes; Mutation; Oleic Acids; Paclitaxel; Permeability; Radiation-Sensitizing Agents; Transplantation, Heterologous | 2006 |
Expression of immediate early genes after treatment of human astrocytoma cells with radiation and taxol.
Topics: Astrocytoma; Base Sequence; Gene Expression Regulation, Neoplastic; Genes, fos; Genes, Immediate-Early; Humans; Molecular Sequence Data; Paclitaxel; Transcriptional Activation; Tumor Cells, Cultured | 1993 |
Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines.
Topics: Adenocarcinoma; Astrocytoma; Breast Neoplasms; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Glycerol; HeLa Cells; Humans; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1993 |
Histologic evidence of a radiosensitizing effect of Taxol in patients with astrocytomas.
Topics: Adult; Antineoplastic Agents, Phytogenic; Astrocytoma; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Retrospective Studies | 1998 |
Taxol, vincristine or nocodazole induces lethality in G1-checkpoint-defective human astrocytoma U373MG cells by triggering hyperploid progression.
Topics: Astrocytoma; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Division; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Enzyme Inhibitors; Fibroblasts; Flow Cytometry; Humans; Hydroxyurea; Karyotyping; Microtubule-Associated Proteins; Nocodazole; Paclitaxel; Phosphorylation; Polyploidy; Retinoblastoma Protein; Thymidine; Tumor Cells, Cultured; Tumor Suppressor Proteins; Vincristine | 1999 |
PCV for oligodendroglial tumors: in search of prognostic factors for response and survival.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cisplatin; Cognition Disorders; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Multivariate Analysis; Oligodendroglioma; Paclitaxel; Prognosis; Survival Analysis; Taxoids; Vinblastine | 2001 |
Characterization of paclitaxel (Taxol) sensitivity in human glioma- and medulloblastoma-derived cell lines.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Astrocytoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Calcium Channel Blockers; Cell Cycle; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Medulloblastoma; Microtubules; Neoplasm Proteins; Paclitaxel; Tumor Cells, Cultured | 1999 |
Taxol: a novel radiation sensitizer.
Topics: Alkaloids; Astrocytoma; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Evaluation; Humans; Interphase; Mitosis; Paclitaxel; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1992 |
Taxol sensitizes human astrocytoma cells to radiation.
Topics: Alkaloids; Astrocytoma; Cell Division; Humans; Paclitaxel; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1992 |